Type 2 diabetes (T2D) is a metabolic disorder characterized by hyperglycemia, hyperinsulinemia and insulin resistance (IR). During the early phase of T2D, insulin synthesis and secretion by pancreatic β cells is enhanced, which can lead to proinsulin (ProIns) misfolding that aggravates endoplasmic reticulum (ER) homeostasis in β cells. Moreover, increased insulin in the circulation may contribute to fatty liver disease. Medical interventions aimed at alleviating ER stress in β cells while maintaining optimal insulin secretion are therefore an attractive therapeutic strategy for T2D. Previously, we demonstrated that germline Chop gene deletion preserved β cells in high fat diet (HFD) fed mice and in leptin receptor-deficient db/db mice. In the current study, we further investigated whether targeting Chop/Ddit3 specifically in murine β cells confers therapeutic benefits. First, we show that Chop deletion in  cells alleviates β cell ER stress and delays glucose-stimulated insulin secretion (GSIS) in HFD fed mice. Second, importantly, β cell-specific Chop deletion prevented liver steatosis and hepatomegaly in aged HFD fed mice without affecting basal glucose homeostasis. Third, we provide the first mechanistic evidence that ER remodeling secondary to Chop deletion modulates glucose-induced islet Ca 2+ oscillations. Finally, using state-of-the-art GLP1-conjugated Chop AntiSense Oligonucleotides (GLP1-Chop ASO), we demonstrated that the Chop deletion induced GSIS change is a long term complex event in β cells. In summary, our results demonstrate that Chop depletion in β cells is a new therapeutic strategy to alleviate dysregulated insulin secretion and the consequently fatty liver disease in T2D.
IR (Fig. S1B , p= 0.31) (17) suggesting unchanged IR in Chop βKO mice. 48 Nonetheless, there was a significant linear correlation between fasting insulin 49 and body weight (Fig. 1C , p< 0.01 by F-test). Furthermore, there was a trend 50 towards decreased cumulative at 4 months (4mon) weight gain in Chop βKO 51 mice ( Fig. 1D, p= 0 .11), which became significant when we included the non- 52 CreERT littermates in comparison ( Fig. S1C, p< 0 .05). Importantly, cumulative 53 weight gain as a function of time was not affected by CreERT gene expression 54 as we previously reported (9) (and data not shown). 55 Given that male Chop βKO mice had relatively normal phenotypes, we next 56 challenged them with a high-fat diet (HFD, 45% fat in kcal) for 20wks starting 57 from an age of ~9 wks, with Chop deletion induced by TAM at 10wks post HFD 58 (scheme shown in Fig. 1E ). In addition, we selected littermates harboring 59 5 wildtype (WT) Chop alleles as the control group as they can be TAM treated. 60 Before Chop deletion, the two groups were metabolically indistinguishable with 61 no significant difference in body weight or blood glucose levels, either before or 62 10wks after the HFD (Fig. 1 F&G) . After Chop deletion, a moderate but 63 significant decrease in body weight was observed in Chop βKO mice (Fig. 1F , p< 64 0.01 at Wk20), which had no effect on blood glucose (Fig. 1G) . After 20wks HFD 65 feeding, murine livers were dissected for visual inspection and for liver 66 triglyceride (TG) analysis. HFD feeding caused hepatomegaly and liver 67 discoloration associated with fatty deposits in control littermates (Fig. 1H, black   68 line), as well as for a Chop βHet mouse in the litter (Fig. 1H, green line) . In 69 contrast, the three Chop βKO mice had normal-sized livers and appeared healthy 70 ( Fig. 1H, red line) . The morphological impression was further confirmed 71 quantitatively by showing significantly reduced liver weight and TG content in 72 Chop βKO mice compared to littermates ( Fig. 1 I and J , p< 0.05 for both). We 73 surmised that chronically reduced β cell insulin secretion may prevent fatty liver 74 development in the HFD-fed C57BL/6 mice, as previously proposed by others (5, 75 6). Supporting this hypothesis, pancreatic insulin content (standardized by tissue 76 wet weight) was reduced 3-fold in the Chop βKO mice (Fig. 1K, p=0 .11 due to 77 variability in the control group) and was positively correlated with TG content ( Fig.   78 1L, p< 0.05 by F-test). Echoing the recently reported human study (7), it will be 79 of interest to investigate if the improvement of fatty liver we observed here 80 reflects reduced de novo hepatic lipogenesis. 81 Intrigued by the blunted GSIS response and the protection from HFD-induced 82 hepatic steatosis observed in the Chop βKO mice (compare Fig. 1B vs. Fig. 1H ), 83 we further evaluated the mice to test whether the reduced pancreatic insulin 84 content negatively affected glucose metabolism. For this purpose, a follow-up 22 85 wk HFD experiment was performed using male mice, during which body weight, 86 food intake and non-fasting blood glucose levels were all monitored. We found 87 no significant differences in these variables at any time point when comparing 88 knockouts to their Chop βHet littermates ( Fig. 2 A to C, respectively), while 89 glucose tolerance in all the HFD fed mice exhibited a significantly increased 90 6 glucose excursion from baseline, as expected (AUC-IPGTT, Fig. 2D , p=0.0001 91 for "HFD" by 2-way ANOVA). In the same experiment, Chop βKO HFD mice were 92 more sensitive to insulin only after Chop deletion, although the difference was not 93 statistically significant (compare Sppl. Fig. 2A and 2B, with TAM administered at 94 8wks post HFD). Similar to the insulin measurements made in the sera from mice 95 fed normal diet ( Fig. 1B) , Chop βKO HFD fed mice had slightly decreased serum 96 C-peptide, both before and after glucose stimulation (Sppl. Fig. S2C ). 97 As we observed no adverse effects of Chop deletion on mouse whole body 98 metabolism, we performed a hyperglycemic clamp test on a different HFD cohort 99 using mice of both sexes ( Fig. 2E) difference was found in HOMA-β nor HOMA-IR ( Fig. S3 A and representing the UPR target genes for the IRE1α, PERK and ATF6α branches of 144 the UPR, respectively, were all found to be significantly reduced ( Fig. 3E) . 145 Reductions in UPR transcript abundance was supported further by our finding 146 that a subset of mRNAs that encode important ER proteins were altered (see 147 heat map in Fig. 3F ), suggesting that CHOP has a long-term effect on "ER 148 remodeling". Since the UPR is an adaptive response to ER stress, we tested with altered ER Ca 2+ signaling, representing a logical outcome from reduced ER 173 stress ( Fig. 3) . 174 For this purpose, we tested the effect of a membrane-permeable intracellular 175 Ca 2+ -chelator, BAPTA-AM (abbreviated as "BAPTA" hereafter). When islets 176 isolated from C57BL/6 mice were exposed overnight to BAPTA (10 µM), we content was also reduced in these islets ( Fig. 4C) . Furthermore, GLP1- Chop-ASO administration was well tolerated by the mice and specifically reduced 213 islet Chop transcript by >60% ( Fig. 4E) , with minimal effects on other C/EBP 214 family members (i.e. Cebpa, Cebpb and Cebpg) in either islets or liver tissues, 215 demonstrating β cell selectivity as reported (33). Further supporting our 216 hypothesis, treatment with GLP1-Chop-ASO reduced the ER Ca 2+ pool without 217 secondarily affecting the cytosolic Ca 2+ levels stimulated by 11 mM glucose 218 (compare Fig. 4F and 4G ), suggesting the change in ER Ca 2+ was a primary 219 event that immediately followed Chop knockdown. To our knowledge, this is the 220 first proof-of-principle that GLP1-ASO strategy can be exploited to alter islet 221 physiology and Ca 2+ dynamics. These results support our working hypothesis 222 featuring an ER-centric role of CHOP in pancreatic β cells (Fig. 3H, Model) .
223
In summary, we propose that CHOP is activated by UPR signaling through the 224 PERK branch, as a response to increased ProIns synthesis and misfolding (34).
225
In turn, CHOP serves as a transcriptional hub to maintain ER proteostasis. This 226 process also controls Insulin transcription, partially via Ca 2+ signaling, from the 227 ER to the nucleus, although this is unlikely directly mediated by CHOP ( Fig. 3H,   228 indicated by the blue arrow on right). Furthermore, ER remodeling in turn has a 229 profound effect on ER Ca 2+ that subsequently contributes to controlling the 230 increase in cytosolic Ca 2+ that occurs in response to elevated glucose (Fig. 3H As the pancreatic islet is a nutrient sensing organ, and β-cells secrete insulin to 237 increase anabolic metabolism upon nutrient availability, we speculate that when 238 there is a surfeit of nutrition, increased insulin secreted into the circulation 239 exacerbates IR and promotes fatty liver in humans (7), although there was a 240 dissociation between HOMA-IR (17) and hyperinsulinemia in Chop βKO mice 241 ( Fig. S1B and S3B) . We were initially intrigued to find that a 75% reduction in 242 Insulin mRNA by Chop deletion did not produce a strong metabolic phenotype in 243 mice, although this was not unprecedented (5, 6, 11) . Insulin mRNA may be in 244 excess in β-cells and crucial for glucose sensing. This may be better explained 245 by a model (Fig. 3H) proposing that ER "stress" due to increased proinsulin 246 synthesis is coupled to insulin secretion, mediated through an "ER Ca 2+ " The Chop floxed (Fe/Fe: Cre) and their wildtype (+/+:Cre) congenic littermates 437 (n=5/group, all male) were fed HFD (45% cal from fat) for 45wks before TAM injections 438 and were continued on HFD for another 8wks before islet isolation. Transcripts encoding 439
Insulin genes (Ins1 and Ins2) and UPR genes were reduced in Chop KO islets. 440
Representative qRT-PCR results from one pair shown (A, B) . The same qRT-PCR 441 experiment was repeated five times using different pairs of mice, e.g. results shown in 442 
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